Log in
Diagnostic Radiology · Diagnostic Radiology of the Abdominal Organs

Liver metastases

Hepatic Metastases

Liver metastases are secondary tumor lesions that require a comprehensive approach to diagnostic imaging for accurate oncological staging. Combining the assessment of morphological structure and metabolic activity allows not only for the detection of lesions but also for the identification of targets for targeted therapy.

SignTarget-type appearance is typical for colorectal cancer metastases
DWI MRIHigh cellular density within the tumor sharply restricts water diffusion
ContrastHepatospecific agents are unable to accumulate in metastases
PET/CTImaging with DOTATATE demonstrates somatostatin receptors
4 min readFor medical studentsUpdated Sep 25, 2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Computed tomography (CT)

CT has the highest sensitivity for detecting small calcifications. Such calcifications often accompany mucin-secreting metastases originating from the gastrointestinal tract. When evaluating the structure on tomograms, the central necrosis zone is clearly distinguishable. A characteristic ring-shaped contrast enhancement (rim enhancement) forms at the periphery of the nodule.

Magnetic resonance imaging (MRI)

In standard sequences, most metastases demonstrate low signal intensity on T1-weighted images and high signal on T2-weighted images. The T2 signal intensity is generally comparable to the splenic parenchyma. With routine gadolinium enhancement in the arterial and portal phases, the MRI picture largely duplicates CT, although small calcifications are practically not visualized here.

Diffusion-weighted imaging (DWI) is of immense diagnostic value ADC. At moderate b-value settings (e.g., b = 500), DWI demonstrates the highest sensitivity to micrometastases. The method is based on the increased cellular density within tumor tissue, which physically restricts the free diffusion of water molecules. On scans, this manifests as a bright hyperintense signal and a decrease in values on apparent diffusion coefficient (ADC) maps. The main advantage of DWI is its high scanning speed and the lack of need for intravenous contrast administration.

Test your knowledge on the topicTasks from the "Diagnostic Radiology" course bank — instant answers and explanations.

Specific contrast agents for MRI

Specialized agents are used to improve the visualization of secondary liver lesions:

  • Iron oxide-based paramagnetics. They are taken up by healthy Kupffer cells. On T2-WI, the signal from normal parenchyma decreases (it darkens), and against this background, metastases that are unable to accumulate iron become distinctly bright and noticeable.
  • Hepatospecific paramagnetics (e.g., gadoxetic acid). Conversely, they increase the signal from healthy liver tissue on T1-WI. Tumor lesions are unable to metabolize such agents, so in delayed hepatobiliary phases, they appear sharply hypointense ("black holes" against a bright background).

Neuroendocrine metastases

Morphologically, they present as multiple round solid nodules.

  • On MRI: On DWI, they show marked diffusion restriction. On T1-WI (gradient echo), the nodules are hypointense, and on fat-suppressed T2-WI, they are moderately hyperintense (their signal is isointense to intrahepatic blood vessels).
  • Contrast enhancement: Upon gadolinium administration, they demonstrate potent hypervascularization followed by rapid washout (washout) into the portal venous and equilibrium phases. If fibrosis has developed within the lesion, contrast accumulation may be delayed.

PET and radionuclide diagnostics

Colloidal radionuclide scintigraphy shows secondary lesions as areas of reduced activity (due to the absence of specialized macrophages—Kupffer cells—within them).

Positron emission tomography (PET) combined with CT or MRI plays an increasingly important role in oncology. For example, routine PET with fluorodeoxyglucose (18F-FDG) assesses glucose metabolism (indicated in prostate cancer and other tumors). At the same time, PET/CT with gallium (Gallium DOTATATE) allows for the detection of somatostatin receptors, which is typical for metastases of pancreatic neuroendocrine tumors.

Hemodynamic masks

Sometimes venous outflow disorders can mimic metastatic involvement. For example, in acute Budd-Chiari syndrome (hepatic vein thrombosis), the peripheral parts of the liver enhance unevenly. An inexperienced specialist might mistake this heterogeneous density decrease on CT for extensive tumor involvement. The situation is complicated by the fact that vascular thrombosis is often secondary to an already existing malignancy.

Briefly: answers to topical questions

What contrast enhancement modes exist for liver MRI with hepatospecific agents?

Liver MRI with hepatospecific agents (such as gadoxetic acid) can utilize multi-phase T1-weighted studies similar to CT, as well as the hepatobiliary phase.

The following scanning modes/phases are distinguished:

  • Arterial phase (arterial phase).
  • Portal phase (portal phase).
  • Delayed phase (delayed phase).
  • Equilibrium phase (equilibrium phase) — described in dynamic contrast enhancement.
  • Hepatobiliary phase (hepatocyte / hepatobiliary phase) — the phase after administration of a hepatotropic contrast agent when normal liver tissue accumulates the contrast; focal lesions may appear differently, which is used for differential diagnosis.
How to memorize

To remember the MRI signal of a typical metastasis, use the rule "Dark beginning, bright end": on T1-WI (first digit) the lesion is hypointense (dark), and on T2-WI (second digit) it is hyperintense (bright, roughly like the spleen).

Class and exam questions

Why do metastases appear dark in the delayed phase when using a hepatospecific contrast agent?

Because metastases do not contain normally functioning hepatocytes. Tumor cells are unable to metabolize and take up this agent, unlike healthy liver parenchyma.

What is the main advantage of diffusion-weighted imaging (DWI) when searching for metastases?

DWI is a very fast method that does not require intravenous contrast administration. By identifying areas of abnormally high cellular density, it is extremely sensitive even to the smallest lesions.

What is the best way to look for calcifications in the liver?

The gold standard for detecting small calcifications (e.g., in mucin-secreting metastases) is computed tomography (CT), since calcifications are usually not visualized on MRI.

Something unclear? Ask the AIThe AI tutor has read the material on "Liver metastases" and will explain it in simple terms.

What else to study on this topic

  • Acute and chronic forms of Budd-Chiari syndrome
  • Portal hypertension: evaluation of portosystemic shunts
  • Portal vein thrombosis and its cavernous transformation
  • Hepatic veno-occlusive disease and indications for biopsy
  • MR angiography and evaluation of collateral circulation

Master the entire topic in the "Diagnostic Radiology" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Liver metastases" and 2,199 more pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 10 video lessons on the subject

Other topics in the section "Diagnostic Radiology of the Abdominal Organs"

Entire section "Diagnostic Radiology of the Abdominal Organs"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.